A Phase 1, Open-Label, 2-Period, 2-Formulation, Within-Subject Crossover Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects Under Fasting Conditions
Latest Information Update: 16 Jun 2022
At a glance
- Drugs Aspirin (Primary) ; Aspirin
- Indications Coronary disorders
- Focus Pharmacodynamics
- Sponsors Rhoshan Pharmaceuticals
- 10 Jun 2022 Status changed from recruiting to completed.
- 29 Dec 2021 New trial record